F Koenen Selected Research

Marker Vaccines

1/2017	Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.
3/2015	Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.
4/2014	Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
11/2005	Evaluation of the epidemiological importance of classical swine fever infected, E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples.
10/2004	Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
11/2001	Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.
10/2001	An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus.
10/2000	An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Koenen Research Topics

Disease

9	Classical Swine Fever (Swine Fever) 01/2017 - 10/2000
6	Infections 03/2015 - 10/2000
2	Disease Progression 10/2001 - 10/2000

Drug/Important Bio-Agent (IBA)

8	Marker VaccinesIBA 01/2017 - 10/2000
4	VaccinesIBA 03/2015 - 11/2001
1	AntibodiesIBA 01/2017
1	Attenuated VaccinesIBA 01/2017
1	EnzymesIBA 12/2012
1	ImmunosorbentsIBA 12/2012
1	ManureIBA 01/2007